...
首页> 外文期刊>Case Reports in Oncology >Advanced Renal Cell Cancer and Low-Dose Palliative Radiation Treatment: A Case of a Substantial and Sustained Treatment Response
【24h】

Advanced Renal Cell Cancer and Low-Dose Palliative Radiation Treatment: A Case of a Substantial and Sustained Treatment Response

机译:晚期肾细胞癌和小剂量姑息性放射治疗:大量且持续的治疗反应

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Clear cell carcinoma is the most common form of renal cell carcinoma (RCC). Metastatic RCC is poorly responsive to treatment and has a bleak prognosis. Newer systemic agents have improved outcomes. Furthermore, their interaction with radiation treatment (RT) may provide further therapeutic options. RCC is considered to be radioresistant, however we report the case of a patient with progression on targeted therapy and immunotherapy who achieved a substantial and sustained local, and possibly abscopal, response to low dose palliative radiation therapy.
机译:透明细胞癌是肾细胞癌(RCC)的最常见形式。转移性RCC对治疗的反应较差,预后很差。较新的全身性药物可改善预后。此外,它们与放射治疗(RT)的相互作用可能会提供更多的治疗选择。 RCC被认为是放射抗性的,但是我们报道了在靶向治疗和免疫治疗方面进展的患者,该患者对低剂量姑息性放射治疗取得了实质性和持续性的局部反应,甚至可能是抽象的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号